BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25481751)

  • 1. Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
    Karlsson J; Lilljebjörn H; Holmquist Mengelbier L; Valind A; Rissler M; Øra I; Fioretos T; Gisselsson D
    Cancer Lett; 2015 Feb; 357(2):498-501. PubMed ID: 25481751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
    Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Karyotypes and Cyclin D1 Immunoreactivity in Clear Cell Sarcoma of the Kidney.
    Jet Aw S; Hong Kuick C; Hwee Yong M; Wen Quan Lian D; Wang S; Liang Loh AH; Ling S; Lian Peh G; Yen Soh S; Pheng Loh AH; Hoon Tan P; Tou En Chang K
    Pediatr Dev Pathol; 2015; 18(4):297-304. PubMed ID: 25751590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney.
    Karlsson J; Valind A; Gisselsson D
    Genes Chromosomes Cancer; 2016 Feb; 55(2):120-3. PubMed ID: 26493387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion.
    Wong MK; Ng CCY; Kuick CH; Aw SJ; Rajasegaran V; Lim JQ; Sudhanshi J; Loh E; Yin M; Ma J; Zhang Z; Iyer P; Loh AHP; Lian DWQ; Wang S; Goh SGH; Lim TH; Lim AST; Ng T; Goytain A; Loh AHL; Tan PH; Teh BT; Chang KTE
    Histopathology; 2018 Jan; 72(2):320-329. PubMed ID: 28833375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
    Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.
    Gooskens SL; Kenny C; Lazaro A; O'Meara E; van Tinteren H; Spreafico F; Vujanic G; Leuschner I; Coulomb-L'Herminé A; Perotti D; de Camargo B; Bergeron C; Acha García T; Tanaka M; Pieters R; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM; O'Sullivan MJ
    Genes Chromosomes Cancer; 2016 Feb; 55(2):143-7. PubMed ID: 26542179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
    Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
    Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney.
    Gooskens SL; Gadd S; Guidry Auvil JM; Gerhard DS; Khan J; Patidar R; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Mullighan CG; Ma J; Jennings LJ; de Krijger RR; van den Heuvel-Eibrink MM; Smith MA; Ross N; Gastier-Foster JM; Perlman EJ
    Oncotarget; 2015 Jun; 6(18):15828-41. PubMed ID: 26158413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
    Kenny C; Bausenwein S; Lazaro A; Furtwängler R; Gooskens SL; van den Heuvel Eibrink M; Vokuhl C; Leuschner I; Graf N; Gessler M; O'Sullivan MJ
    J Pathol; 2016 Apr; 238(5):617-20. PubMed ID: 27000436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney.
    O'Meara E; Stack D; Lee CH; Garvin AJ; Morris T; Argani P; Han JS; Karlsson J; Gisselson D; Leuschner I; Gessler M; Graf N; Fletcher JA; O'Sullivan MJ
    J Pathol; 2012 May; 227(1):72-80. PubMed ID: 22294382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
    Han H; Bertrand KC; Patel KR; Fisher KE; Roy A; Muscal JA; Venkatramani R
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28151. PubMed ID: 31876361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication.
    Santiago T; Clay MR; Azzato E; Newman S; Fernandez-Pineda I; Nichols KE; Zhang J; Downing JR; Davidoff A; Brennan RC; Ellison DW
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney.
    Kenny C; McDonagh N; Lazaro A; O'Meara E; Klinger R; O'Connor D; Roche F; Hokamp K; O'Sullivan MJ
    J Pathol; 2018 Mar; 244(3):334-345. PubMed ID: 29243812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney.
    Ueno-Yokohata H; Okita H; Nakasato K; Akimoto S; Hata J; Koshinaga T; Fukuzawa M; Kiyokawa N
    Nat Genet; 2015 Aug; 47(8):861-3. PubMed ID: 26098867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWS/ETS fusions activate telomerase in Ewing's tumors.
    Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
    Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.